title: Multiple endocrine neoplasia type 1 gene expression is normal in sporadic adrenocortical tumors.
abstract: Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder with neoplasia of the anterior pituitary, the parathyroid, the endocrine pancreas and other endocrine tissues including the adrenal cortex. The tumor-suppressor gene causing this disease was identified at the gene locus 11q13. We recently reported that adrenocortical carcinomas frequently show loss of heterozygosity (LOH) of 11q13, but do not contain point mutations within the MEN1-coding region. To investigate whether reduced gene expression (for example by mutations within the MEN1 promoter) may contribute to the tumorigenesis of sporadic adrenocortical tumors, 24 adrenocortical specimen were studied by Northern blot analysis. This series included six adrenocortical carcinomas, four cortisol-producing adenomas, six aldosterone-producing adenomas, three endocrine-inactive adenomas and six normal adrenal glands. The presence of LOH of 11q13 was investigated using five polymorphic microsatellite markers (D11S956, PYGM, D11S4939, D11S4946 and D11S987) close to the MEN1 gene. Poly-A mRNA was hybridized with a PCR-generated cDNA probe of the MEN1 gene, a cDNA of the former MEN1 candidate gene phospholipase (PLC) beta3 and a mouse beta-actin cDNA for normalization. LOH of 11q13 was detected in five out of six carcinomas and two inactive adenomas, but in none of the hormone-producing adenomas. Compared with normal adrenals (100+/-6. 5%, mean+/-s.e.m.) MEN1 mRNA in adrenocortical tumors was expressed in similar amounts (carcinomas 109+/-11%, cortisol-producing adenomas 131+/-10%, aldosterone-producing adenomas 113+/-13%, endocrine-inactive adenomas 111+/-2%) with the exception of one adrenocortical carcinoma with low MEN1 mRNA expression (66%). PLCbeta3 mRNA expression showed a variable pattern without reaching significant differences between the groups. We conclude that since mRNA levels were unaltered in the majority of tumors, mutations of the MEN1 gene causing altered gene transcription is unlikely to be a major pathogenic factor of sporadic adrenocortical tumors.
authors.affiliation: Clinic for Endocrinology and Metabolism, University of Mainz, Germany.
authors.forename: O
authors.initials: O
authors.lastname: Zwermann
authors.forename: F
authors.initials: F
authors.lastname: Beuschlein
authors.forename: P
authors.initials: P
authors.lastname: Mora
authors.forename: G
authors.initials: G
authors.lastname: Weber
authors.forename: B
authors.initials: B
authors.lastname: Allolio
authors.forename: M
authors.initials: M
authors.lastname: Reincke
mesh_terms: D000236:Adenoma / Q000235:genetics / Q000378:metabolism*; D000306:Adrenal Cortex Neoplasms / Q000235:genetics / Q000378:metabolism*; D000311:Adrenal Glands / Q000378:metabolism; D000450:Aldosterone / Q000096:biosynthesis; D002277:Carcinoma / Q000235:genetics / Q000378:metabolism*; D015870:Gene Expression; D006801:Humans; D006854:Hydrocortisone / Q000096:biosynthesis; D019656:Loss of Heterozygosity; D018761:Multiple Endocrine Neoplasia Type 1 / Q000235:genetics*; D012333:RNA, Messenger / Q000378:metabolism; D012016:Reference Values
chemical_list: D012333:RNA, Messenger; D000450:Aldosterone; D006854:Hydrocortisone